ARTICA BIOTECH S.A.

Artica Biotech S.A. is a global supplier of animal derived products of Fetal Bovine Serum. Since its establishment in 2013, the company has prioritized offering the highest quality products and exceptional service to its customers. With a focus on integrated cooperation, Artica controls product quality from the top of the supply chain and provides customized products and services to global customers. The materials are sourced from abattoirs with export qualification in Uruguay, ensuring complete traceability for products. The company's single batch size can reach 3000 bottles, with an annual production capacity of 150,000 liters. Raw materials undergo processing through sequential filters and aseptic dispensing before freezing. All serum products are manufactured in strictly controlled environments to meet quality standards. In the latest funding round, Artica Biotech S.A. secured a CNY100.00M Series B investment on 10 May 2023. The investors included Shenzhen Investment Holdings Co., LTD, Puen Zerui, ABC International, Jinpu Muhe. The investment is expected to further support the company's expansion and innovation efforts in the Biopharma, Biotechnology, Life Sciences, and Manufacturing industries.